{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:09:22Z","timestamp":1778728162322,"version":"3.51.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-026-01717-7","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:18:41Z","timestamp":1775045921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Hypothesis-Generating Pharmacologic Profile for Sargramostim Treatment of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"46","clinical-trial-number":[{"clinical-trial-number":"nct03790670","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8941-985X","authenticated-orcid":false,"given":"Susmita","family":"Sil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7321-5040","authenticated-orcid":false,"given":"Xiaoqing","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1884-1360","authenticated-orcid":false,"given":"Samia","family":"Akter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4717-610X","authenticated-orcid":false,"given":"Mohit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davina B.","family":"Oludipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8206-7470","authenticated-orcid":false,"given":"Arnab","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4792-0416","authenticated-orcid":false,"given":"Guoku","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie R.","family":"Ostlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gleb R.","family":"Haynatzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4241-6149","authenticated-orcid":false,"given":"R. Lee","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-0370","authenticated-orcid":false,"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"1","key":"1717_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7(1):47. https:\/\/doi.org\/10.1038\/s41572-021-00280-3","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"1717_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.958","volume":"12","author":"MM Abdelmoaty","year":"2022","unstructured":"Abdelmoaty MM, Machhi J, Yeapuri P, Shahjin F, Kumar V, Olson KE, Mosley RL, Gendelman HE (2022) Monocyte biomarkers define sargramostim treatment outcomes for Parkinson\u2019s disease. Clin Transl Med 12(7):e958. https:\/\/doi.org\/10.1002\/ctm2.958","journal-title":"Clin Transl Med"},{"key":"1717_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2022.102211","volume":"71","author":"KA Aly","year":"2022","unstructured":"Aly KA, Moutaoufik MT, Zilocchi M, Phanse S, Babu M (2022) Insights into SACS pathological attributes in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)\u2606. Curr Opin Chem Biol 71:102211. https:\/\/doi.org\/10.1016\/j.cbpa.2022.102211","journal-title":"Curr Opin Chem Biol"},{"issue":"2","key":"1717_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1128\/MCB.23.2.721-732.2003","volume":"23","author":"LA Anderson","year":"2003","unstructured":"Anderson LA, Perkins ND (2003) Regulation of RelA (p65) function by the large subunit of replication factor C. Mol Cell Biol 23(2):721\u2013732. https:\/\/doi.org\/10.1128\/MCB.23.2.721-732.2003","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1717_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12079-015-0288-4","volume":"9","author":"LA Bach","year":"2015","unstructured":"Bach LA (2015) Recent insights into the actions of IGFBP-6. J Cell Commun Signal 9(2):189\u2013200. https:\/\/doi.org\/10.1007\/s12079-015-0288-4","journal-title":"J Cell Commun Signal"},{"issue":"6","key":"1717_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41590-018-0103-5","volume":"19","author":"J Borlido","year":"2018","unstructured":"Borlido J, Sakuma S, Raices M, Carrette F, Tinoco R, Bradley LM, D\u2019Angelo MA (2018) Nuclear pore complex-mediated modulation of TCR signaling is required for naive CD4(+) T cell homeostasis. Nat Immunol 19(6):594\u2013605. https:\/\/doi.org\/10.1038\/s41590-018-0103-5","journal-title":"Nat Immunol"},{"issue":"6","key":"1717_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrm.2017.11","volume":"18","author":"MT Butler","year":"2017","unstructured":"Butler MT, Wallingford JB (2017) Planar cell polarity in development and disease. Nat Rev Mol Cell Biol 18(6):375\u2013388. https:\/\/doi.org\/10.1038\/nrm.2017.11","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"19","key":"1717_CR8","doi-asserted-by":"publisher","first-page":"12305","DOI":"10.1074\/jbc.272.19.12305","volume":"272","author":"BZ Carter","year":"1997","unstructured":"Carter BZ, Wiseman AL, Orkiszewski R, Ballard KD, Ou CN, Lieberman MW (1997) Metabolism of leukotriene C4 in gamma-glutamyl transpeptidase-deficient mice. J Biol Chem 272(19):12305\u201312310. https:\/\/doi.org\/10.1074\/jbc.272.19.12305","journal-title":"J Biol Chem"},{"key":"1717_CR9","doi-asserted-by":"publisher","DOI":"10.1242\/dev.168112","author":"J Casal","year":"2018","unstructured":"Casal J, Ibanez-Jimenez B, Lawrence PA (2018) Planar cell polarity: the prickle gene acts independently on both the Ds\/Ft and the Stan\/Fz systems. Development. https:\/\/doi.org\/10.1242\/dev.168112","journal-title":"Development"},{"issue":"4","key":"1717_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12439","volume":"13","author":"DT Chemparathy","year":"2024","unstructured":"Chemparathy DT, Ray S, Ochs C, Ferguson N, Gawande DY, Dravid SM, Callen S, Sil S, Buch S (2024) Neuropathogenic role of astrocyte-derived extracellular vesicles in HIV-associated neurocognitive disorders. J Extracell Vesicles 13(4):e12439. https:\/\/doi.org\/10.1002\/jev2.12439","journal-title":"J Extracell Vesicles"},{"issue":"5","key":"1717_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nn1443","volume":"8","author":"L Chen","year":"2005","unstructured":"Chen L, Feany MB (2005) Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 8(5):657\u2013663. https:\/\/doi.org\/10.1038\/nn1443","journal-title":"Nat Neurosci"},{"issue":"11","key":"1717_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac535","volume":"9","author":"TK Chen","year":"2022","unstructured":"Chen TK, Batra JS, Michalik DE, Casillas J, Patel R, Ruiz ME, Hara H, Patel B, Kadapakkam M, Ch\u2019Ng J, Small CB, Zagaliotis P, Ragsdale CE, Leal LO, Roilides E, Walsh TJ (2022) Recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) as adjuvant therapy for invasive fungal diseases. Open Forum Infect Dis 9(11):ofac535. https:\/\/doi.org\/10.1093\/ofid\/ofac535","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"1717_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jnnp-2021-327788","volume":"93","author":"L Chouliaras","year":"2022","unstructured":"Chouliaras L, Thomas A, Malpetti M, Donaghy P, Kane J, Mak E, Savulich G, Prats-Sedano MA, Heslegrave AJ, Zetterberg H, Su L, Rowe JB, O\u2019Brien JT (2022) Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer\u2019s disease, frontotemporal dementia and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 93(6):651\u2013658. https:\/\/doi.org\/10.1136\/jnnp-2021-327788","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"1717_CR14","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114824","volume":"13","author":"JJ Collier","year":"2021","unstructured":"Collier JJ, Suomi F, Olahova M, McWilliams TG, Taylor RW (2021) Emerging roles of ATG7 in human health and disease. EMBO Mol Med 13(12):e14824. https:\/\/doi.org\/10.15252\/emmm.202114824","journal-title":"EMBO Mol Med"},{"key":"1717_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","volume":"42","author":"H Deng","year":"2018","unstructured":"Deng H, Wang P, Jankovic J (2018) The genetics of Parkinson disease. Ageing Res Rev 42:72\u201385. https:\/\/doi.org\/10.1016\/j.arr.2017.12.007","journal-title":"Ageing Res Rev"},{"issue":"s1","key":"1717_CR16","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8(s1):S3\u2013S8. https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"1717_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.nurt.2007.12.001","volume":"5","author":"SA Factor","year":"2008","unstructured":"Factor SA (2008) Current status of symptomatic medical therapy in Parkinson\u2019s disease. Neurotherapeutics 5(2):164\u2013180. https:\/\/doi.org\/10.1016\/j.nurt.2007.12.001","journal-title":"Neurotherapeutics"},{"issue":"2","key":"1717_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/cvr\/cvt244","volume":"101","author":"A Fessner","year":"2014","unstructured":"Fessner A, Esser JS, Bluhm F, Grundmann S, Zhou Q, Patterson C, Bode C, Moser M (2014) The transcription factor HoxB5 stimulates vascular remodelling in a cytokine-dependent manner. Cardiovasc Res 101(2):247\u2013255. https:\/\/doi.org\/10.1093\/cvr\/cvt244","journal-title":"Cardiovasc Res"},{"issue":"3","key":"1717_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","volume":"68","author":"M Funayama","year":"2023","unstructured":"Funayama M, Nishioka K, Li Y, Hattori N (2023) Molecular genetics of Parkinson\u2019s disease: contributions and global trends. J Hum Genet 68(3):125\u2013130. https:\/\/doi.org\/10.1038\/s10038-022-01058-5","journal-title":"J Hum Genet"},{"key":"1717_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100690","volume":"45","author":"RP Gale","year":"2021","unstructured":"Gale RP, Armitage JO (2021) Use of molecularly-cloned haematopoietic growth factors in persons exposed to acute high-dose, high-dose rate whole-body ionizing radiations. Blood Rev 45:100690. https:\/\/doi.org\/10.1016\/j.blre.2020.100690","journal-title":"Blood Rev"},{"issue":"10","key":"1717_CR21","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/bmt.2013.57","volume":"48","author":"RP Gale","year":"2013","unstructured":"Gale RP, Vorobiov A (2013) First use of myeloid colony-stimulating factors in humans. Bone Marrow Transpl 48(10):1358. https:\/\/doi.org\/10.1038\/bmt.2013.57","journal-title":"Bone Marrow Transpl"},{"key":"1717_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-017-0013-5","volume":"3","author":"HE Gendelman","year":"2017","unstructured":"Gendelman HE, Zhang Y, Santamaria P, Olson KE, Schutt CR, Bhatti D, Shetty BLD, Lu Y, Estes KA, Standaert DG, Heinrichs-Graham E, Larson L, Meza JL, Follett M, Forsberg E, Siuzdak G, Wilson TW, Peterson C, Mosley RL (2017) Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson\u2019s disease trial. NPJ Parkinsons Dis 3:10. https:\/\/doi.org\/10.1038\/s41531-017-0013-5","journal-title":"NPJ Parkinsons Dis"},{"issue":"2\u20133","key":"1717_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s0014-5793(03)00634-3","volume":"546","author":"V Goebeler","year":"2003","unstructured":"Goebeler V, Ruhe D, Gerke V, Rescher U (2003) Atypical properties displayed by annexin A9, a novel member of the annexin family of Ca(2+) and lipid binding proteins. FEBS Lett 546(2\u20133):359\u2013364. https:\/\/doi.org\/10.1016\/s0014-5793(03)00634-3","journal-title":"FEBS Lett"},{"issue":"1","key":"1717_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-025-01582-5","volume":"25","author":"SD Hall","year":"2025","unstructured":"Hall SD, Tran K, Zhu J, Su T, McHugh CA (2025) DUBR non-coding RNA regulates gene expression by affecting AP-1 enhancer accessibility. Funct Integr Genomics 25(1):68. https:\/\/doi.org\/10.1007\/s10142-025-01582-5","journal-title":"Funct Integr Genomics"},{"issue":"4","key":"1717_CR25","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA, Young RA (2013) Super-enhancers in the control of cell identity and disease. Cell 155(4):934\u2013947. https:\/\/doi.org\/10.1016\/j.cell.2013.09.053","journal-title":"Cell"},{"issue":"17","key":"1717_CR26","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1001\/jama.2014.13943","volume":"312","author":"FS Hodi","year":"2014","unstructured":"Hodi FS, Lee S, McDermott DF, Rao UN, Butterfield LH, Tarhini AA, Leming P, Puzanov I, Shin D, Kirkwood JM (2014) Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial. JAMA 312(17):1744\u20131753. https:\/\/doi.org\/10.1001\/jama.2014.13943","journal-title":"JAMA"},{"issue":"8","key":"1717_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020) Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91(8):795\u2013808. https:\/\/doi.org\/10.1136\/jnnp-2019-322338","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"23","key":"1717_CR28","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1101\/gad.1600707","volume":"21","author":"G Juhasz","year":"2007","unstructured":"Juhasz G, Erdi B, Sass M, Neufeld TP (2007) Atg7-dependent autophagy promotes neuronal health, stress tolerance, and longevity but is dispensable for metamorphosis in Drosophila. Genes Dev 21(23):3061\u20133066. https:\/\/doi.org\/10.1101\/gad.1600707","journal-title":"Genes Dev"},{"issue":"8","key":"1717_CR29","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1136\/gutjnl-2016-313466","volume":"67","author":"V Klepsch","year":"2018","unstructured":"Klepsch V, Gerner RR, Klepsch S, Olson WJ, Tilg H, Moschen AR, Baier G, Hermann-Kleiter N (2018) Nuclear orphan receptor NR2F6 as a safeguard against experimental murine colitis. Gut 67(8):1434\u20131444. https:\/\/doi.org\/10.1136\/gutjnl-2016-313466","journal-title":"Gut"},{"issue":"10","key":"1717_CR30","doi-asserted-by":"publisher","first-page":"17156","DOI":"10.18632\/oncotarget.15052","volume":"8","author":"S Kohi","year":"2017","unstructured":"Kohi S, Sato N, Koga A, Matayoshi N, Hirata K (2017) KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer. Oncotarget 8(10):17156\u201317163. https:\/\/doi.org\/10.18632\/oncotarget.15052","journal-title":"Oncotarget"},{"issue":"21","key":"1717_CR31","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1056\/NEJMoa041109","volume":"352","author":"JR Korzenik","year":"2005","unstructured":"Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ, Sargramostim in Crohn\u2019s Disease Study G (2005) Sargramostim for active Crohn\u2019s disease. N Engl J Med 352(21):2193\u20132201. https:\/\/doi.org\/10.1056\/NEJMoa041109","journal-title":"N Engl J Med"},{"issue":"4","key":"1717_CR32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3934\/Neuroscience.2019.4.333","volume":"6","author":"MG Krokidis","year":"2019","unstructured":"Krokidis MG (2019) Identification of biomarkers associated with Parkinson\u2019s disease by gene expression profiling studies and bioinformatics analysis. AIMS Neurosci 6(4):333\u2013345. https:\/\/doi.org\/10.3934\/Neuroscience.2019.4.333","journal-title":"AIMS Neurosci"},{"key":"1717_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cells13141173","author":"M Kumar","year":"2024","unstructured":"Kumar M, Swanson N, Ray S, Buch S, Saraswathi V, Sil S (2024) Astrocytes in amyloid generation and alcohol metabolism: implications of alcohol use in neurological disorder(s). Cells. https:\/\/doi.org\/10.3390\/cells13141173","journal-title":"Cells"},{"issue":"3","key":"1717_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1182\/blood-2009-06-230094","volume":"115","author":"B Laurent","year":"2010","unstructured":"Laurent B, Randrianarison-Huetz V, Marechal V, Mayeux P, Dusanter-Fourt I, Dumenil D (2010) High-mobility group protein HMGB2 regulates human erythroid differentiation through trans-activation of GFI1B transcription. Blood 115(3):687\u2013695. https:\/\/doi.org\/10.1182\/blood-2009-06-230094","journal-title":"Blood"},{"key":"1717_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.706186","volume":"12","author":"HM Lazarus","year":"2021","unstructured":"Lazarus HM, Ragsdale CE, Gale RP, Lyman GH (2021) Sargramostim (rhu GM-CSF) as cancer therapy (systematic review) and an immunomodulator. A drug before its time? Front Immunol 12:706186. https:\/\/doi.org\/10.3389\/fimmu.2021.706186","journal-title":"Front Immunol"},{"issue":"2","key":"1717_CR36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00441-016-2458-y","volume":"366","author":"W Li","year":"2016","unstructured":"Li W, Wu ZQ, Zhang S, Cao R, Zhao J, Sun ZJ, Zou W (2016) Augmented expression of gamma-glutamyl transferase 5 (GGT5) impairs testicular steroidogenesis by deregulating local oxidative stress. Cell Tissue Res 366(2):467\u2013481. https:\/\/doi.org\/10.1007\/s00441-016-2458-y","journal-title":"Cell Tissue Res"},{"issue":"1","key":"1717_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02382-5","volume":"19","author":"N Liu","year":"2022","unstructured":"Liu N, Bai L, Lu Z, Gu R, Zhao D, Yan F, Bai J (2022) TRPV4 contributes to ER stress and inflammation: implications for Parkinson\u2019s disease. J Neuroinflammation 19(1):26. https:\/\/doi.org\/10.1186\/s12974-022-02382-5","journal-title":"J Neuroinflammation"},{"key":"1717_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073880","author":"W Liu","year":"2024","unstructured":"Liu W, Du C, Nan L, Li C, Wang H, Fan Y, Zhang S (2024) The difference of milk-derived extracellular vesicles from cow colostrum and mature milk on miRNAs expression and protecting intestinal epithelial cells against lipopolysaccharide damage. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25073880","journal-title":"Int J Mol Sci"},{"key":"1717_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cells13181527","author":"A Mahboob","year":"2024","unstructured":"Mahboob A, Ali H, AlNaimi A, Yousef M, Rob M, Al-Muhannadi NA, Senevirathne DKL, Chaari A (2024) Immunotherapy for Parkinson\u2019s disease and Alzheimer\u2019s disease: a promising disease-modifying therapy. Cells. https:\/\/doi.org\/10.3390\/cells13181527","journal-title":"Cells"},{"key":"1717_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10040850","author":"S Mankhong","year":"2022","unstructured":"Mankhong S, Kim S, Lee S, Kwak HB, Park DH, Joa KL, Kang JH (2022) Development of Alzheimer\u2019s disease biomarkers: from CSF- to blood-based biomarkers. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10040850","journal-title":"Biomedicines"},{"issue":"8007","key":"1717_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/s0140-6736(77)91146-1","volume":"1","author":"CD Marsden","year":"1977","unstructured":"Marsden CD, Parkes JD (1977) Success and problems of long-term levodopa therapy in Parkinson\u2019s disease. Lancet 1(8007):345\u2013349. https:\/\/doi.org\/10.1016\/s0140-6736(77)91146-1","journal-title":"Lancet"},{"issue":"2","key":"1717_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1006\/abbi.2001.2368","volume":"390","author":"M Negishi","year":"2001","unstructured":"Negishi M, Pedersen LG, Petrotchenko E, Shevtsov S, Gorokhov A, Kakuta Y, Pedersen LC (2001) Structure and function of sulfotransferases. Arch Biochem Biophys 390(2):149\u2013157. https:\/\/doi.org\/10.1006\/abbi.2001.2368","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"1717_CR43","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4103\/1673-5374.293140","volume":"16","author":"SL Nickels","year":"2021","unstructured":"Nickels SL, Schwamborn JC (2021) Is serine racemase (SRR) a second hit target for LRRK2-G2019S induced Parkinson\u2019s disease? Neural Regen Res 16(3):498\u2013499. https:\/\/doi.org\/10.4103\/1673-5374.293140","journal-title":"Neural Regen Res"},{"issue":"2","key":"1717_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/imm.12507","volume":"146","author":"RA O\u2019Connor","year":"2015","unstructured":"O\u2019Connor RA, Anderton SM (2015) Inflammation-associated genes: risks and benefits to Foxp3\u2009+\u2009regulatory T-cell function. Immunology 146(2):194\u2013205. https:\/\/doi.org\/10.1111\/imm.12507","journal-title":"Immunology"},{"issue":"1","key":"1717_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-023-00361-1","volume":"12","author":"KE Olson","year":"2023","unstructured":"Olson KE, Abdelmoaty MM, Namminga KL, Lu Y, Obaro H, Santamaria P, Mosley RL, Gendelman HE (2023a) An open-label multiyear study of sargramostim-treated Parkinson\u2019s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers. Transl Neurodegener 12(1):26. https:\/\/doi.org\/10.1186\/s40035-023-00361-1","journal-title":"Transl Neurodegener"},{"key":"1717_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coph.2015.10.006","volume":"26","author":"KE Olson","year":"2016","unstructured":"Olson KE, Gendelman HE (2016) Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson\u2019s disease. Curr Opin Pharmacol 26:87\u201395. https:\/\/doi.org\/10.1016\/j.coph.2015.10.006","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"1717_CR47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/cei\/uxac084","volume":"211","author":"KE Olson","year":"2023","unstructured":"Olson KE, Mosley RL, Gendelman HE (2023b) The potential for treg-enhancing therapies in nervous system pathologies. Clin Exp Immunol 211(2):108\u2013121. https:\/\/doi.org\/10.1093\/cei\/uxac084","journal-title":"Clin Exp Immunol"},{"key":"1717_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021a.103380","volume":"67","author":"KE Olson","year":"2021","unstructured":"Olson KE, Namminga KL, Lu Y, Schwab AD, Thurston MJ, Abdelmoaty MM, Kumar V, Wojtkiewicz M, Obaro H, Santamaria P, Mosley RL, Gendelman HE (2021aa) Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson\u2019s disease. EBioMedicine 67:103380. https:\/\/doi.org\/10.1016\/j.ebiom.2021a.103380","journal-title":"EBioMedicine"},{"key":"1717_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021b.120786","volume":"272","author":"KE Olson","year":"2021","unstructured":"Olson KE, Namminga KL, Lu Y, Thurston MJ, Schwab AD, de Picciotto S, Tse SW, Walker W, Iacovelli J, Small C, Wipke BT, Mosley RL, Huang E, Gendelman HE (2021bb) Granulocyte-macrophage colony-stimulating factor mRNA and neuroprotective immunity in Parkinson\u2019s disease. Biomaterials 272:120786. https:\/\/doi.org\/10.1016\/j.biomaterials.2021b.120786","journal-title":"Biomaterials"},{"issue":"7\u20138","key":"1717_CR50","doi-asserted-by":"publisher","first-page":"e2629","DOI":"10.1093\/milmed\/usac362","volume":"188","author":"R Paine","year":"2023","unstructured":"Paine R, Chasse R, Halstead ES, Nfonoyim J, Park DJ, Byun T, Patel B, Molina-Pallete G, Harris ES, Garner F, Simms L, Ahuja S, McManus JL, Roychowdhury DF (2023) Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-associated acute hypoxemia: results of the phase 2, randomized, open-label trial (iLeukPulm). Mil Med 188(7\u20138):e2629\u2013e2638. https:\/\/doi.org\/10.1093\/milmed\/usac362","journal-title":"Mil Med"},{"key":"1717_CR51","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cellsig.2018.01.022","volume":"45","author":"SW Pang","year":"2018","unstructured":"Pang SW, Lahiri C, Poh CL, Tan KO (2018) PNMA family: protein interaction network and cell signalling pathways implicated in cancer and apoptosis. Cell Signal 45:54\u201362. https:\/\/doi.org\/10.1016\/j.cellsig.2018.01.022","journal-title":"Cell Signal"},{"issue":"15","key":"1717_CR52","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","volume":"284","author":"Parkinson Study G","year":"2000","unstructured":"Parkinson Study G (2000) Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group JAMA 284(15):1931\u20131938. https:\/\/doi.org\/10.1001\/jama.284.15.1931","journal-title":"Parkinson Study Group JAMA"},{"issue":"6","key":"1717_CR53","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","volume":"18","author":"L Parnetti","year":"2019","unstructured":"Parnetti L, Gaetani L, Eusebi P, Paciotti S, Hansson O, El-Agnaf O, Mollenhauer B, Blennow K, Calabresi P (2019) Csf and blood biomarkers for Parkinson\u2019s disease. Lancet Neurol 18(6):573\u2013586. https:\/\/doi.org\/10.1016\/S1474-4422(19)30024-9","journal-title":"Lancet Neurol"},{"key":"1717_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/biom10060912","author":"A Polissidis","year":"2020","unstructured":"Polissidis A, Petropoulou-Vathi L, Nakos-Bimpos M, Rideout HJ (2020) The future of targeted gene-based treatment strategies and biomarkers in Parkinson\u2019s disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom10060912","journal-title":"Biomolecules"},{"issue":"1","key":"1717_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12158","volume":"7","author":"H Potter","year":"2021","unstructured":"Potter H, Woodcock JH, Boyd TD, Coughlan CM, O\u2019Shaughnessy JR, Borges MT, Thaker AA, Raj BA, Adamszuk K, Scott D, Adame V, Anton P, Chial HJ, Gray H, Daniels J, Stocker ME, Sillau SH (2021) Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer\u2019s disease. Alzheimers Dement (N Y) 7(1):e12158. https:\/\/doi.org\/10.1002\/trc2.12158","journal-title":"Alzheimers Dement (N Y)"},{"key":"1717_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008538.pub2","volume":"11","author":"L Roth","year":"2011","unstructured":"Roth L, Macdonald JK, McDonald JW, Chande N (2011) Sargramostim (GM-CSF) for induction of remission in Crohn\u2019s disease. Cochrane Database Syst Rev 11:CD008538. https:\/\/doi.org\/10.1002\/14651858.CD008538.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"1717_CR57","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.2174\/1570159X16666180222165418","volume":"16","author":"Q Rui","year":"2018","unstructured":"Rui Q, Ni H, Li D, Gao R, Chen G (2018) The role of LRRK2 in neurodegeneration of Parkinson disease. Curr Neuropharmacol 16(9):1348\u20131357. https:\/\/doi.org\/10.2174\/1570159X16666180222165418","journal-title":"Curr Neuropharmacol"},{"key":"1717_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11030555","author":"SW Ryter","year":"2022","unstructured":"Ryter SW (2022) Heme oxygenase-1: an anti-inflammatory effector in cardiovascular, lung, and related metabolic disorders. Antioxidants. https:\/\/doi.org\/10.3390\/antiox11030555","journal-title":"Antioxidants"},{"issue":"1","key":"1717_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.trsl.2015.06.011","volume":"167","author":"SW Ryter","year":"2016","unstructured":"Ryter SW, Choi AM (2016) Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res 167(1):7\u201334. https:\/\/doi.org\/10.1016\/j.trsl.2015.06.011","journal-title":"Transl Res"},{"issue":"12","key":"1717_CR60","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1096\/fj.201600698R","volume":"30","author":"MB Schaaf","year":"2016","unstructured":"Schaaf MB, Keulers TG, Vooijs MA, Rouschop KM (2016) LC3\/GABARAP family proteins: autophagy-(un)related functions. FASEB J 30(12):3961\u20133978. https:\/\/doi.org\/10.1096\/fj.201600698R","journal-title":"FASEB J"},{"issue":"1","key":"1717_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0255-7","volume":"13","author":"CR Schutt","year":"2018","unstructured":"Schutt CR, Gendelman HE, Mosley RL (2018) Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson\u2019s disease. Mol Neurodegener 13(1):26. https:\/\/doi.org\/10.1186\/s13024-018-0255-7","journal-title":"Mol Neurodegener"},{"issue":"16","key":"1717_CR62","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1128\/MCB.21.16.5389-5395.2001","volume":"21","author":"ZZ Shi","year":"2001","unstructured":"Shi ZZ, Han B, Habib GM, Matzuk MM, Lieberman MW (2001) Disruption of gamma-glutamyl leukotrienase results in disruption of leukotriene D(4) synthesis in vivo and attenuation of the acute inflammatory response. Mol Cell Biol 21(16):5389\u20135395. https:\/\/doi.org\/10.1128\/MCB.21.16.5389-5395.2001","journal-title":"Mol Cell Biol"},{"issue":"5","key":"1717_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000660","volume":"18","author":"S Sil","year":"2020","unstructured":"Sil S, Hu G, Liao K, Niu F, Callen S, Periyasamy P, Fox HS, Buch S (2020) HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1alpha\/lncRNA BACE1-AS axis. PLoS Biol 18(5):e3000660. https:\/\/doi.org\/10.1371\/journal.pbio.3000660","journal-title":"PLoS Biol"},{"issue":"6","key":"1717_CR64","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.14336\/AD.2021.0406","volume":"12","author":"S Sil","year":"2021","unstructured":"Sil S, Singh S, Chemparathy DT, Chivero ET, Gordon L, Buch S (2021) Astrocytes & astrocyte derived extracellular vesicles in Morphine induced amyloidopathy: implications for cognitive deficits in opiate abusers. Aging Dis 12(6):1389\u20131408. https:\/\/doi.org\/10.14336\/AD.2021.0406","journal-title":"Aging Dis"},{"issue":"1","key":"1717_CR65","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1172\/JCI93924","volume":"128","author":"JJ Song","year":"2018","unstructured":"Song JJ, Oh SM, Kwon OC, Wulansari N, Lee HS, Chang MY, Lee E, Sun W, Lee SE, Chang S, An H, Lee CJ, Lee SH (2018) Cografting astrocytes improves cell therapeutic outcomes in a Parkinson\u2019s disease model. J Clin Invest 128(1):463\u2013482. https:\/\/doi.org\/10.1172\/JCI93924","journal-title":"J Clin Invest"},{"issue":"2","key":"1717_CR66","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3233\/JPD-212976","volume":"12","author":"YY Tan","year":"2022","unstructured":"Tan YY, Jenner P, Chen SD (2022) Monoamine oxidase-B inhibitors for the treatment of Parkinson\u2019s disease: past, present, and future. J Parkinsons Dis 12(2):477\u2013493. https:\/\/doi.org\/10.3233\/JPD-212976","journal-title":"J Parkinsons Dis"},{"key":"1717_CR67","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/bs.irn.2017.03.003","volume":"132","author":"N Titova","year":"2017","unstructured":"Titova N, Qamar MA, Chaudhuri KR (2017) Biomarkers of Parkinson\u2019s disease: an introduction. Int Rev Neurobiol 132:183\u2013196. https:\/\/doi.org\/10.1016\/bs.irn.2017.03.003","journal-title":"Int Rev Neurobiol"},{"key":"1717_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02234","volume":"9","author":"A van Nieuwenhuijze","year":"2018","unstructured":"van Nieuwenhuijze A, Burton O, Lemaitre P, Denton AE, Cascalho A, Goodchild RE, Malengier-Devlies B, Cauwe B, Linterman MA, Humblet-Baron S, Liston A (2018) Mice deficient in nucleoporin Nup210 develop peripheral T cell alterations. Front Immunol 9:2234. https:\/\/doi.org\/10.3389\/fimmu.2018.02234","journal-title":"Front Immunol"},{"key":"1717_CR69","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/719167","volume":"2012","author":"SD Vassar","year":"2012","unstructured":"Vassar SD, Bordelon YM, Hays RD, Diaz N, Rausch R, Mao C, Vickrey BG (2012) Confirmatory factor analysis of the motor unified Parkinson\u2019s disease rating scale. Parkinsons Dis 2012:719167. https:\/\/doi.org\/10.1155\/2012\/719167","journal-title":"Parkinsons Dis"},{"issue":"1","key":"1717_CR70","doi-asserted-by":"publisher","first-page":"L125","DOI":"10.1152\/ajplung.00074.2019","volume":"318","author":"SH Vitali","year":"2020","unstructured":"Vitali SH, Fernandez-Gonzalez A, Nadkarni J, Kwong A, Rose C, Mitsialis SA, Kourembanas S (2020) Heme oxygenase-1 dampens the macrophage sterile inflammasome response and regulates its components in the hypoxic lung. Am J Physiol Lung Cell Mol Physiol 318(1):L125\u2013L134. https:\/\/doi.org\/10.1152\/ajplung.00074.2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"1717_CR71","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.molcel.2022.12.002","volume":"83","author":"L Wang","year":"2023","unstructured":"Wang L, Cai J, Zhao X, Ma L, Zeng P, Zhou L, Liu Y, Yang S, Cai Z, Zhang S, Zhou L, Yang J, Liu T, Jin S, Cui J (2023) Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy. Mol Cell 83(2):281\u2013297e210. https:\/\/doi.org\/10.1016\/j.molcel.2022.12.002","journal-title":"Mol Cell"},{"issue":"1","key":"1717_CR72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2217\/epi.13.73","volume":"6","author":"Z Wang","year":"2014","unstructured":"Wang Z, Qin G, Zhao TC (2014) HDAC4: mechanism of regulation and biological functions. Epigenomics 6(1):139\u2013150. https:\/\/doi.org\/10.2217\/epi.13.73","journal-title":"Epigenomics"},{"key":"1717_CR73","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2024.13355","author":"M Xiao","year":"2024","unstructured":"Xiao M, Xue J, Jin E (2024) SPOCK: Master regulator of malignant tumors (Review). Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2024.13355","journal-title":"Mol Med Rep"},{"key":"1717_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1379967","volume":"15","author":"S Yeudall","year":"2024","unstructured":"Yeudall S, Upchurch CM, Leitinger N (2024) The clinical relevance of heme detoxification by the macrophage heme oxygenase system. Front Immunol 15:1379967. https:\/\/doi.org\/10.3389\/fimmu.2024.1379967","journal-title":"Front Immunol"},{"issue":"7","key":"1717_CR75","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00702-019-02001-3","volume":"126","author":"R Yilmaz","year":"2019","unstructured":"Yilmaz R, Hopfner F, van Eimeren T, Berg D (2019) Biomarkers of Parkinson\u2019s disease: 20 years later. J Neural Transm 126(7):803\u2013813. https:\/\/doi.org\/10.1007\/s00702-019-02001-3","journal-title":"J Neural Transm"},{"issue":"sup1","key":"1717_CR76","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1080\/09553002.2019.1673499","volume":"97","author":"Y Zhong","year":"2021","unstructured":"Zhong Y, Pouliot M, Downey AM, Mockbee C, Roychowdhury D, Wierzbicki W, Authier S (2021) Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model. Int J Radiat Biol 97(sup1):S100\u2013S116. https:\/\/doi.org\/10.1080\/09553002.2019.1673499","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"1717_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06643-4","volume":"15","author":"X Zhou","year":"2024","unstructured":"Zhou X, Zhao J, Yan T, Ye D, Wang Y, Zhou B, Liu D, Wang X, Zheng W, Zheng B, Qian F, Li Y, Li D, Fang L (2024) ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway. Cell Death Dis 15(4):260. https:\/\/doi.org\/10.1038\/s41419-024-06643-4","journal-title":"Cell Death Dis"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01717-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01717-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01717-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:24:34Z","timestamp":1778725474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-026-01717-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1717"],"URL":"https:\/\/doi.org\/10.1007\/s10571-026-01717-7","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The research study protocol was approved by the UNMC Institutional Review Board (IRB Protocol 839\u2009\u2212\u200918). Primary care physicians or the study neurologist identified and referred each subject to the clinical research center. Subjects were enrolled after the study physician obtained informed consent in accordance with reasonable clinical practice guidelines. All subjects in the study were on treatment, so no randomization or blinding was performed. The trial is registered on ClinicalTrials.gov under the identifier NCT03790670.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"All authors have consented to the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"87"}}